These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27294357)

  • 41. Circulating tight junction proteins mirror blood-brain barrier integrity in leukaemia central nervous system metastasis.
    Zhu JC; Si MY; Li YZ; Chen HZ; Fan ZC; Xie QD; Jiao XY
    Hematol Oncol; 2017 Sep; 35(3):365-373. PubMed ID: 26999811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
    Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
    JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.
    Rubenstein JL; Wong VS; Kadoch C; Gao HX; Barajas R; Chen L; Josephson SA; Scott B; Douglas V; Maiti M; Kaplan LD; Treseler PA; Cha S; Hwang JH; Cinque P; Cyster JG; Lowell C
    Blood; 2013 Jun; 121(23):4740-8. PubMed ID: 23570798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical diagnostic significance of cerebrospinal fluid detection with flow cytometry in children acute lymphoblastic leukemia accompanied by central nervous system leukemia].
    Yang WY; Wang HJ; Chen YM; Chen XJ; Zou Y; Guo Y; Wang SC; Liu TF; Zhu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):38-42. PubMed ID: 22391161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
    Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
    Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central Nervous System Lymphoma.
    Shah T; Venur VA
    Semin Neurol; 2023 Dec; 43(6):825-832. PubMed ID: 37995744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
    Heger JM; Mattlener J; Schneider J; Gödel P; Sieg N; Ullrich F; Lewis R; Bucaciuc-Mracica T; Schwarz RF; Rueß D; Ruge MI; Montesinos-Rongen M; Deckert M; Blau T; Kutsch N; Balke-Want H; Weiss J; Becker K; Reinhardt HC; Hallek M; Borchmann P; von Tresckow B; Borchmann S
    Blood; 2024 Feb; 143(6):522-534. PubMed ID: 37946299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
    Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
    Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central nervous system lymphoma: a morphological MRI study.
    Koubska E; Weichet J; Malikova H
    Neuro Endocrinol Lett; 2016 Sep; 37(4):318-324. PubMed ID: 27857050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
    Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
    Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
    van Westrhenen A; Smidt LCA; Seute T; Nierkens S; Stork ACJ; Minnema MC; Snijders TJ
    Br J Haematol; 2018 Aug; 182(3):384-403. PubMed ID: 29808930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
    Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
    J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
    Lossos IS; Breuer R; Intrator O; Lossos A
    Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma.
    Strowd RE; Abuali IA; Grossman SA
    CNS Oncol; 2015; 4(3):131-5. PubMed ID: 25905905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal fluid approach on neuro-oncology.
    Gomes HR
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.
    Mao X; Sun Y; Tang J
    Neurol Sci; 2014 Feb; 35(2):233-8. PubMed ID: 23832112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteopontin: its potential role in cancer of children and young adults.
    Karpinsky G; Fatyga A; Krawczyk MA; Chamera M; Sande N; Szmyd D; Izycka-Swieszewska E; Bien E
    Biomark Med; 2017 Apr; 11(4):389-402. PubMed ID: 28326824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
    Kivisäkk P; Healy BC; Francois K; Gandhi R; Gholipour T; Egorova S; Sevdalinova V; Quintana F; Chitnis T; Weiner HL; Khoury SJ
    Mult Scler; 2014 Apr; 20(4):438-44. PubMed ID: 24005026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.